Login / Signup
Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR T-cell therapy.
Binod Dhakal
Sameem Abedin
Timothy Fenske
Saurabh Chhabra
Nathan Ledeboer
Parameswaran N Hari
Mehdi Hamadani
Published in:
Blood (2021)
Keyphrases
</>
cell therapy
sars cov
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
stem cells
peritoneal dialysis
mesenchymal stem cells
prognostic factors
patient reported outcomes
coronavirus disease
patient reported